Tiotropium

This is not medical advice. Always consult a licensed healthcare professional before starting or changing any treatment. Information here is based on personal experiences and may not apply to everyone.

Alternative Names: Spiriva

Tiotropium is a long-acting muscarinic antagonist (LAMA) used as maintenance therapy for COPD. It works by blocking muscarinic receptors in the airways, leading to bronchodilation and improved airflow. Taken once daily via inhaler, tiotropium helps reduce symptoms like shortness of breath and decreases the frequency of exacerbations. It is especially beneficial for patients with moderate to severe COPD who require long-term bronchodilation. Common side effects include dry mouth and, less commonly, urinary retention or constipation.

Treatment Type: Prescription Medication

Treatment Class: Muscarinic antagnoist

Treatment Modality: Inhalation

Review Summary

5.0

1 Reviews

Preferred by 1 Reviewers

Based on the review, Tiotropium is highly recommended for treating Chronic Obstructive Pulmonary Disease (COPD) according to GOLD guidelines. It is considered a first-line maintenance therapy for moderate to severe COPD and can be used alone or in combination with other medications, demonstrating its effectiveness in managing the disease.

This summary was generated by users' reviews

Breakdown by Category

Each categories are rated on a 1–5 scale, with 5 being the most favorable outcome and 1 being the least. These scores are averaged across all user reviews to provide a clear sense of how this treatment typically performs in each area.

Cost

3.0

1 = Very Expensive 5 = Very Affordable

3.0

Moderate Cost

Relief Speed

2.0

1 = No Relief 5 = Immediate Relief

2.0

Slow Relief

Side Effects

4.0

1 = Intolerable Effect 5 = No Effect

4.0

Mild Effect

Treatment Line

5.0

1 = Third-line or more 5 = First-line

5.0

First-line

Choose treatments from the menu above to see how they compare side by side.

5.0

1 Reviews

100%

AI Summary of User Experiences

Not medical advice.

Reviews

Filter by reviewer type Pro

Select all Clear all

Cost

Very Expensive

$1000+

Expensive

$501 to $1000

Moderate Cost

$101 to $500

Affordable

$25 to $100

Very Affordable

$25

Relief Speed

No Relief

No noticeable improvement

Slow Relief

Several days to weeks

Moderate Relief

Within 1 - 3 days

Fast Relief

Within hours

Immediate Relief

Within minutes

Side Effect

Intolerable Side Effect

Caused treatment to stop or required hospitalization

Severe Side Effect

Difficult to tolerate, may require intervention

Moderate Side Effect

Noticeable, but manageable

Mild Side Effect

Minor, not bothersome

No Side Effect

Without any adverse effects

Treatment Line

Third-line or more

Used after second-line failed or multiple prior treatment

Second-line

Used after first-line treatment failed or was unsuitable

First-line

First treatment tried

Dr. Curbside

Verified

Physician • Emergency Medicine • How doctors think about decisions — and what real-world experiences add

2 months ago

Tiotropium, a long-acting muscarinic antagonist, is recommended by GOLD guidelines as a first-line maintenance therapy for patients with moderate to severe COPD. It can be used alone or combined with a LABA or ICS, depending on disease severity and exacerbation risk.

#ReviewersPreferred #ModerateCost #CoveredByInsurance #SlowRelief #MildEffect #First-line #Maintenance

View Professional Disclosures

We use cookies to personalize our services and provide you with the best possible experience. By continuing to use this site, you agree to this cookie usage. We also use third-party cookies that help us analyse how you use this website, store your preferences, and provide the content and advertisements that are relevant to you. These cookies will only be stored in your browser with your prior consent. You can learn more about cookies and how your data is processed in the Privacy Policy.

Strictly Necessary Only Accept All